Back to LPL Financial LLC LPL Financial LLC

XLOXLO

4 quarters

Position history for LPL Financial LLCLPL Financial LLC's holdings in Xilio Therapeutics, Inc.

No. LPL Financial exited its XLO (Xilio Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 21,000 shares worth $13,444. LPL Financial first reported XLO in Q2 2025 and held it in 3 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$21,077

Total Shares Change

-31,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$8.41
0
2025-Q4
Decreased
21,000
-32.3%
$13,4440.0%$8.96
0
2025-Q3
Unchanged
31,000
0.0%
$26,1240.0%$11.80
0
2025-Q2
New
31,000
—
$21,0770.0%$9.52
29

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used